About Us
Vivesto is a specialty pharmaceutical company focused on the development of new therapeutic options for patients suffering from hard-to-treat cancers.
-
Regulatory November 30, 2022Vivesto announces that Christer Nordstedt will remain as acting CEO during a transition period
-
Regulatory November 21, 2022Vivesto appoints Erik Kinnman as CEO
-
Regulatory November 21, 2022Nomination Committee appointed for the 2023 Annual General Meeting in Vivesto
Vivesto published its Q3 report for 2022 on November 17, 2022, at 08.00 am CET.